Gates Package — page 31
of 1375 pages
← p.30 p.32 → · this page in the original PDF · package
Second NHP Study Results -- Preliminary - 1
Three arm, vehicle controlled study administering
favipiravir twice a day
250 mg/kg favipiravir BID on Day 0, maintenance dose
regimen of 150 mg/kg BID on Days 1-13.
125 mg BID on Day 0 followed by 75 mg BID on Days 113 (expected similar exposure to influenza regimen)
EBOV challenge the day favipiravir started
Favipiravir administered BID by oral gavage
Animals sedated twice a day
Confidential
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/31
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:exh:00019 | — | attachment | 31 |